Structure

InChI Key GZKLJWGUPQBVJQ-UHFFFAOYSA-N
Smile O=C1NCCN1CCN1CCC(c2cn(-c3ccc(F)cc3)c3ccc(Cl)cc23)CC1
InChI
InChI=1S/C24H26ClFN4O/c25-18-1-6-23-21(15-18)22(16-30(23)20-4-2-19(26)3-5-20)17-7-10-28(11-8-17)13-14-29-12-9-27-24(29)31/h1-6,15-17H,7-14H2,(H,27,31)

Physicochemical Descriptors

Property Name Value
Molecular Formula C24H26ClFN4O
Molecular Weight 440.95
AlogP 4.63
Hydrogen Bond Acceptor 3.0
Hydrogen Bond Donor 1.0
Number of Rotational Bond 5.0
Polar Surface Area 40.51
Molecular species BASE
Aromatic Rings 3.0
Heavy Atoms 31.0

Pharmacology

Action Mechanism of Action Reference
ANTAGONIST Adrenergic receptor alpha-1 antagonist PubMed PubMed PubMed PubMed

Indications

Mesh Heading Maximum Phase Mesh ID Reference
Schizophrenia 3 D012559 ClinicalTrials
Anxiety 3 D001007 ClinicalTrials
Dementia 3 D003704 ClinicalTrials
Depressive Disorder 3 D003866 ClinicalTrials

Related Entries

Scaffolds

Cross References

Resources Reference
ChEBI 9122
ChEMBL CHEMBL12713
DrugBank DB06144
DrugCentral 2435
EPA CompTox DTXSID6048967
FDA SRS GVV4Z879SP
Human Metabolome Database HMDB0015618
Guide to Pharmacology 98
KEGG C07567
PharmGKB PA164784002
SureChEMBL SCHEMBL112092
ZINC ZINC000000538337